Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81Leukemia 41Gastrointestinal Stromal Tumors 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Leukemia, Myeloid, Chronic-Phase 27Blast Crisis 13Neoplasms 10Neoplasm Metastasis 10Melanoma 10Brain Neoplasms 10Lung Neoplasms 9Prostatic Neoplasms 8Leukemia, Myeloid, Acute 8Gliosarcoma 8Glioblastoma 8Leukemia, Myeloid, Accelerated Phase 7Glioma 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 5Philadelphia Chromosome 5Oligodendroglioma 5Recurrence 4Primary Myelofibrosis 4Polycythemia Vera 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 4Astrocytoma 4

Interventions

Cyclophosphamide 46fludarabine phosphate 34Peripheral Blood Stem Cell Transplantation 29Whole-Body Irradiation 22Etoposide 22Tacrolimus 20Methotrexate 20Mycophenolic Acid 19Cytarabine 19Dexamethasone 17Vincristine 16Filgrastim 16Busulfan 16venetoclax 15Antilymphocyte Serum 15Rituximab 13Prednisone 13Cyclosporine 12Doxorubicin 11Melphalan 9Calcium Dobesilate 9nelarabine 8Bortezomib 8merphos 7Radiotherapy 7Methylprednisolone 7Granulocyte Colony-Stimulating Factor 7Azacitidine 7prednylidene 6pegaspargase 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Imatinib Mesylate × Clear all
NCT01005914 2023-01-06

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
11 enrolled 6 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02538926 2018-11-14

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

University of Washington

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡